VeriMomtranexamoyl sh-pentapeptide-12 sp hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specifically for "tranexamoyl sh‑pentapeptide‑12 sp" identified, and no peer‑reviewed reproductive toxicity data were found indicating teratogenicity or reproductive hazard for the peptide conjugate. Parent compound (tranexamic acid) has systemic pharmacology when dosed systemically but topical cosmetic use of peptide conjugates offers negligible systemic exposure in the absence of data to the contrary (sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem/CosIng).
Related ingredients
Frequently asked questions
- tranexamoyl sh-pentapeptide-12 sp hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment specifically for "tranexamoyl sh‑pentapeptide‑12 sp" identified, and no peer‑reviewed reproductive toxicity data were found indicating teratogenicity or reproductive hazard for the peptide conjugate. Parent compound (tranexamic acid) has systemic pharmacology when dosed systemically but topical cosmetic use of peptide conjugates offers negligible systemic exposure in the absence of data to the contrary (sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem/CosIng).
- tranexamoyl sh-pentapeptide-12 sp emzirirken güvenli mi?
- No data indicating reproductive or lactation hazard for this cosmetic peptide. No harmonised hazard classification or SCCS/CIR opinion found. Given expected minimal dermal absorption of a peptide conjugate from cosmetic use, systemic exposure via breastmilk is unlikely.
- tranexamoyl sh-pentapeptide-12 sp bebek cildi için güvenli mi?
- No infant‑specific toxicology identified. Hazard and mechanism: no evidence of developmental or endocrine activity for the peptide conjugate. Exposure: infant skin has higher relative absorption and immature barrier—so exposure score increased by +1 versus adult (from 0 to 1) despite expectation of low systemic absorption for the topical peptide.
- VeriMom tranexamoyl sh-pentapeptide-12 sp nasıl puanlıyor?
- VeriMom tranexamoyl sh-pentapeptide-12 sp'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tranexamoyl sh-pentapeptide-12 sp yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.